Viewing Study NCT01501669


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-05 @ 6:25 PM
Study NCT ID: NCT01501669
Status: UNKNOWN
Last Update Posted: 2012-07-18
First Post: 2011-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Sponsor: National Cancer Center, Korea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None irinotecan View
None capecitabine View
None metastatic breast cancer View